Mai 20. 2020

Mayer Brown advised SERB Group on the acquisition of the Veriton Pharma Group

Share

Paris – Mayer Brown advised SERB Specialty Pharmaceuticals (« SERB »), independent pharmaceutical company in connection with the acquisition of the Veriton Pharma Limited Group, a British pharmaceutical group, from its founder-manager and other members of the management team. 

Mayer Brown advised SERB on the structuring of the acquisition with a team composed of Laurent Borey, Olivier Parawan (partners) and Sarah Rahmoun (associate) in Paris and Matthew Mortimer (partner) and Matthew O'Brien (associate) in London.


verwandte Beratungsfelder und Industrien

Beratungsfelder

Industrien

Stay Up To Date With Our Insights

See how we use a multidisciplinary, integrated approach to meet our clients' needs.
Subscribe